You are here

The Progress Report Keep up-to-date with our community. From science coverage to fundraiser spotlights, get the latest news here.

BCRF investigator Elizabeth Comen discusses her collaboration with BCRF researcher Dr. Sohail Tavazoie in developing a blood test to reduce unnecessary biopsies.
A study led by BCRF investigator Fergus Couch has shown that 54 BRCA2 variants of uncertain clinical significance are likely to be associated with an increased risk of breast or ovarian cancer.
In Part Three of our series, we explain how to adopt a balanced lifestyle to achieve your wellness goals.
BCRF researchers have uncovered new information about inherited risk of breast cancer for women of Ashkenazi (European) Jewish ancestry. The report was recently published in JAMA Oncology.
FDA approves the first PARP inhibitor for the treatment of HER2-negative metastatic breast cancer in patients with BRCA mutations.
Research by BCRF investigators shows that tumor DNA collected by liquid biopsy can identify patients at risk of poor outcome.
BCRF investigator Nikhil Wagle discusses the importance of minority population participation in clinical trials.
In Part Two of our prevention series, we highlight the importance of exercise in breast cancer prevention.
In Part One of our prevention series, we explain the science behind maintaining a healthy weight.
Our series focuses on sharing evidence-based tips to maintaining a healthy lifestyle.